Treatment Adherence
Conditions
Keywords
type 2 diabetes, colchicine, inflammatory markers
Brief summary
Colchicine has antidiabetic effect and may be an option for type 2 diabetes management
Detailed description
Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with 30 females and 20 males after written consent from all patients. The ages of all patients were between 35 and 55 years. The aim of this study was to evaluate colchicine effect on A1C of newly diagnosed type2 diabetes compared to the metformin and control group on diet only. The first group patients received colchicine 0.5twice daily for 6 months, the second group received metformin 1gm twice daily, the third group patients were on diet only. During the period of treatment, the investigators followed the patients if there were side effects of the drugs used. No side effects were monitored during the period of treatment except for gastric upset in some patients using metformin
Interventions
colchicine tabletes for 6 months
Sponsors
Ministry of Health and Population, Egypt
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
35 Years to 55 Years
Inclusion criteria
* type 2 diabetes newly diagnosed age 35- 55 years
Exclusion criteria
* severe anemia hypothyroidism and hyperthyroidism moderate to severe liver or kidney disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| colchicine for treatment of type diabetes patients | 6 months | colchicine tablets .5 mg twice daily for 6 months |
Countries
Egypt
Outcome results
None listed